"10.1371_journal.pone.0020404","plos one","2011-05-24T00:00:00Z","Cristina Vilaplana; Olga Gil; Neus Cáceres; Sergio Pinto; Jorge Díaz; Pere-Joan Cardona","Unitat de Tuberculosi Experimental, Fundació Institut per a la Investigació en Ciències de la Salut Germans Trias i Pujol, Universitat Autònoma de Barcelona, Crta Badalona, Catalonia, Spain; CIBER Enfermedades Respiratorias, Bunyola, Balears, Spain","Conceived and designed the experiments: CV P-JC. Performed the experiments: CV OG SP NC JD P-JC. Analyzed the data: CV P-JC. Contributed reagents/materials/analysis tools: CV P-JC. Wrote the paper: CV P-JC.","The authors have read the journals policy and have the following conflicts. PJC is co-inventor of the patents for RUTI® as a therapeutic vaccine, prophylactic vaccine and as primary prophylaxis against TB. Regulatory approval and development is being undertaken by a spin-out biopharma company (Archivel Farma, S.L.) in collaboration with the Institut Germans Trias i Pujol. PJC is the scientific director of this development. Archivel Farma S.L. partly funded this study. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","05","Cristina Vilaplana","CV",6,TRUE,2,6,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
